IP Library Granted Patent US 7,341,682
Granted Patent B2
US 7,341,682 · App. 10/512,301 · Granted Mar 11, 2008

Manufacture of polysaccharide beads

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,341,682
App. No.
10/512,301
Granted
Mar 11, 2008
Kind
B2
Abstract

The present invention is a process of manufacture of one or more polysaccharide beads, comprising generating an aerosol of an aqueous polysaccharide solution, cooling the droplets of said aerosol in air to initiate gelling thereof and collecting droplets as gelled beads in a liquid or on a surface, characterised by adding a hydrophilic vapour pressure-lowering agent to said polysaccharide solution.

Claims (10)

1. In a process of manufacture of one or more polysaccharide beads, comprising generating an aerosol of droplets of an aqueous polysaccharide solution in air, cooling the droplets of said aerosol in air to initiate gelling thereof and collecting droplets as gelled beads in a liquid or on a surface, the improvement comprising adding a hydrophilic vapour pressure-lowering agent to said polysaccharide solution to reduce skin formation on the bead surface.

2. The process of claim 1 , wherein the vapour pressure-lowering agent includes molecules of a molecular weight below about 200 D, and is defined by a vapour pressure below about 310 mbar at 70° C.

3. The process of claim 1 , wherein the vapour pressure-lowering agent results in a surface tension above about 50 mN/m at 10 wt % concentration in water at 25° C.

4. The process of claim 1 , wherein the vapour pressure-lowering lowering agent is an organic substance.

5. The process of claim 1 , wherein the vapour pressure-lowering agent is selected from the group consisting of glycols and glycerols.

6. The process of claim 5 , wherein the vapour pressure-lowering agent is propylene glycol.

7. The process of claim 1 , wherein the aerosol is generated by a spinning disk technique.

8. The process of claim 1 , wherein the aqueous polysaccharide droplets are cooled in an essentially steam-saturated atmosphere.

9. The process of claim 1 , wherein the polysaccharide solution includes a chemical cross-linker.

10. The process of claim 1 , wherein the polysaccharide is agarose.

Assignments (4)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2004
From: ANDERSSON, RALF GORAN; BERG, HANS; JONSSON, INGEMAR; LARSSON, ANDERS
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 015351/0204 →